Showing results (751-760 of 2,388) with videos related to
Sort By:
Pageof 239
Digestive Diseases (Basel, Switzerland)|August 7, 1999
Complications and lessons learned from 10 years of expandable gastrointestinal prosthesesR A KozarekDigestive Diseases (Basel, Switzerland)|March 4, 2000
Biliary complications of orthotopic liver transplantationB Y Tung, M B KimmeyDigestive Diseases (Basel, Switzerland)|November 5, 1999
Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going?A LonardoDigestive Diseases (Basel, Switzerland)|November 5, 1999
Clinical features of celiac disease todayP Collin, K Kaukinen, M MäkiDigestive Diseases (Basel, Switzerland)|April 20, 1999
Genetics of inflammatory bowel disease. The candidate gene approach: susceptibility versus disease heterogeneityA S PeñaDigestive Diseases (Basel, Switzerland)|November 4, 2000
New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitorsL J Egan, J A MurrayDigestive Diseases (Basel, Switzerland)|October 18, 2017
Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus InfectionHiroshi Ida, Satoru Hagiwara, Masashi Kono, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2017
Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2Tadaaki Arizumi, Tomohiro Minami, Hirokazu Chishina, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2017
Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2Tadaaki Arizumi, Tomohiro Minami, Hirokazu Chishina, et al.Digestive Diseases (Basel, Switzerland)|October 18, 2017
Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute ExperienceKazuomi Ueshima, Naoshi Nishida, Masatoshi KudoPageof 239